Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial (Q35125893)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial |
scientific article |
Statements
1 reference
Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial (English)
1 reference
Sagar Lonial
1 reference
Kenneth C Anderson
1 reference
Paul G Richardson
1 reference
Jacob P Laubach
1 reference
Donna E Reece
1 reference
Noopur S Raje
1 reference
Robert L Schlossman
1 reference
Dixie-Lee Esseltine
1 reference
Colleen K Harvey
1 reference
Craig C Hofmeister
1 reference
Sandra M Wear
1 reference
Andrzej J Jakubowiak
1 reference
Kent A Griffith
1 reference
Todd M Zimmerman
1 reference
Erica L Campagnaro
1 reference
Tara Anderson
1 reference
Melissa A Mietzel
1 reference
Jennifer C Barrickman
1 reference
Craig L Tendler
1 reference
Susan L Kelley
1 reference
Mark S Kaminski
1 reference
19 May 2011
1 reference
1 reference
118
1 reference
3
1 reference
535-543
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference